Lab7 Systems Secures $3.0M Series A Financing

LAB7 SYSTEMS SECURES $3.0M FINANCING TO FUEL PLATFORM GROWTH AND COMMERCIAL EXPANSIONBoosts scalable software platform for data-intensive life science applications

AUSTIN, TX – Lab7 Systems, Inc., a leader in workflow management for data-intensive life science applications, announced today the closing of $3.0 million of its planned $5.0 million Series A financing. The company’s Enterprise Science Platform (ESP) enables life science laboratories to manage complex sample-to-answer workflows in data-intensive environments. The company also curates BioBuilds, a hub for the distribution of Open Source bioinformatics tools. Lab7 seeks to accelerate life science innovation by integrating next-generation, computationally intense tools into research practice, while maintaining data provenance and supporting compliance with current regulatory regimes.

“We will utilize this financing to enhance our core software platform and build out our team of talented software developers and bioinformaticians,” said

< | >